Related Experiment Video
Updated: Feb 26, 2026

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
Published on: January 12, 2020
Non-canonical NOTCH3 signalling limits tumour angiogenesis
Shuheng Lin1, Ana Negulescu1, Sirisha Bulusu1
1Apoptosis, Cancer and Development Laboratory-Equipe labellisée 'La Ligue', LabEx DEVweCAN, Centre de Recherche en Cancérologie de Lyon, INSERM U1052-CNRS UMR5286, Université de Lyon, Centre Léon Bérard, 69008 Lyon, France.
Abstract:
Notch signalling is a causal determinant of cancer and efforts have been made to develop targeted therapies to inhibit the so-called canonical pathway. Here we describe an unexpected pro-apoptotic role of Notch3 in regulating tumour angiogenesis independently of the Notch canonical pathway. The Notch3 ligand Jagged-1 is upregulated in a fraction of human cancer and our data support the view that Jagged-1, produced by cancer cells, is inhibiting the apoptosis induced by the aberrant Notch3 expression in tumour vasculature. We thus present Notch3 as a dependence receptor inducing endothelial cell death while this pro-apoptotic activity is blocked by Jagged-1. Along this line, using Notch3 mutant mice, we demonstrate that tumour growth and angiogenesis are increased when Notch3 is silenced in the stroma. Consequently, we show that the well-documented anti-tumour effect mediated by γ-secretase inhibition is at least in part dependent on the apoptosis triggered by Notch3 in endothelial cells.
Insights
Notch3 promotes cancer cell death and inhibits tumor growth by triggering endothelial cell apoptosis. Jagged-1 blocks this effect, revealing a new therapeutic target for cancer treatment.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Notch signalling is a key driver of cancer, with targeted therapies focusing on the canonical pathway.
- The role of Notch3 in tumour angiogenesis and its interaction with ligands like Jagged-1 is not fully understood.
Purpose of the Study:
- To investigate the non-canonical role of Notch3 in regulating tumour angiogenesis.
- To elucidate the mechanism by which Jagged-1 influences Notch3-mediated endothelial cell apoptosis.
- To assess the therapeutic implications of targeting Notch3 in cancer.
Main Methods:
- Utilized Notch3 mutant mice to study tumour growth and angiogenesis.
- Investigated the interaction between Notch3 and its ligand Jagged-1 in cancer models.
- Analyzed the effect of γ-secretase inhibition on tumour vasculature and endothelial cell apoptosis.
Main Results:
- Notch3 exhibits a pro-apoptotic role in tumour vasculature, independent of the canonical Notch pathway.
- Cancer-derived Jagged-1 inhibits Notch3-induced endothelial cell death, promoting tumour growth and angiogenesis.
- Tumour growth and angiogenesis are increased in Notch3-silenced mice.
- The anti-tumour effects of γ-secretase inhibitors are partly mediated by Notch3-induced endothelial cell apoptosis.
Conclusions:
- Notch3 acts as a dependence receptor, inducing endothelial cell death, a process inhibited by Jagged-1.
- Targeting the Notch3-Jagged-1 interaction presents a novel therapeutic strategy for cancer.
- Understanding this non-canonical Notch3 function is crucial for developing effective cancer therapies.
Related Concept Videos
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Regulation of Angiogenesis and Blood Supply
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Non-Canonical Wnt Signaling Pathways
Mechanism of Angiogenesis

